|
Real-time Estimate
Cboe BZX
22:32:20 17/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 88.42 USD | -1.49% |
|
+0.97% | +33.34% |
| 08-13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
| 08-04 | Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 94.12 | +4.87% | 25 | |||||||
| 119.4 | +7.33% | 25 | |||||||
| 98.44 | +7.86% | 25 | |||||||
| 372.58 | +18.73% | 12 | |||||||
| 30,553.33 | +14.67% | 15 | |||||||
| 194.42 | +6.01% | 12 | |||||||
| 44.62 | +24.83% | 26 | |||||||
| 3,110 | +16.37% | 13 | |||||||
| 404.73 | +15.83% | 15 | |||||||
| 263.12 | +12.79% | 8 | |||||||
| 229.79 | +23.87% | 14 | |||||||
| 107.57 | +6.88% | 21 | |||||||
| 93.92 | +6.02% | 13 | |||||||
| 40.3 | -5.68% | 11 | |||||||
| 28.73 | +7.47% | 11 | |||||||
| 208.6 | +15.05% | 15 | |||||||
| 103.23 | +20.18% | 13 | |||||||
| 171.91 | +19.93% | 22 | |||||||
| 289.25 | -2.74% | 20 | |||||||
| 329 | -7.65% | 5 | |||||||
| Average | 1,842.85 | +10.63% | 16 | ||||||
| Weighted average by Cap. | 2,528.97 | +10.49% | 19 |
- Stock Market
- Stocks
- DXCM Stock
- Sector DexCom, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















